USPTO Patent Application for Bioimplant Alloy

The United States Patent and Trademark Office (USPTO) has published patent application US20260085389A1, filed on September 23, 2024, by KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS. The application details a non-equiatomic high entropy alloy (HEA) composed of titanium, zirconium, niobium, tantalum, and silver, specifically formulated for bioimplant applications. The claimed benefits include enhanced corrosion resistance, anti-bacterial properties, and a reduced elastic modulus compared to existing materials.

This publication represents a patent application, not a final granted patent or a regulatory rule. It signifies the disclosure of an invention and its potential use in medical devices. While not imposing direct compliance obligations on manufacturers, it highlights potential future technological advancements in the prosthetics and bioimplant field. Companies involved in the development or manufacturing of bioimplants should monitor the progress of this and similar patent applications as they may indicate emerging trends or future intellectual property landscapes in the medical device sector.